These links suggest that obesity-associated circulating factors may be suppressing ERβ expression in HER2+ breast cancer cells by further amplifying HER2 signaling, resulting in AP-1 activation and the subsequent inhibition of ERβ gene transcription. Here, ESR2 is linked to obesity due to melanocortin 4 receptor deficiency.